Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
TEL-AVIV, Israel, May 28, 2013 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the “Company” or “RedHill”), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, patent-protected, new formulations and combinations of existing drugs, today announced that Guy Goldberg, Chief Business Officer, will present an overview of the Company at the Jefferies 2013 Global Healthcare Conference on Monday, June 3, 2013 at 10:30am EDT at The Grand Hyatt Hotel in New York City.
Help employers find you! Check out all the jobs and post your resume.
